Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Author Correction: Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS trial

Title:	Author Correction: Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS trial
Authors:	Usmani, Saad Z.^{Aff1, IDs41591025035812_cor1}; Facon, Thierry^Aff2; Hungria, Vania^Aff3; Bahlis, Nizar J.^Aff4; Venner, Christopher P.^{Aff5, Aff6}; Braunstein, Marc^Aff7; Pour, Ludek^Aff8; Martí, Josep M.^Aff9; Basu, Supratik^Aff10; Cohen, Yael C.^{Aff11, Aff12}; Matsumoto, Morio^Aff13; Suzuki, Kenshi^Aff14; Hulin, Cyrille^Aff15; Grosicki, Sebastian^Aff16; Legiec, Wojciech^Aff17; Beksac, Meral^Aff18; Maiolino, Angelo^{Aff19, Aff20}; Takamatsu, Hiroyuki^Aff21; Perrot, Aurore^Aff22; Turgut, Mehmet^Aff23; Ahmadi, Tahamtan^Aff24; Liu, Weiping^Aff25; Wang, Jianping^Aff26; Chastain, Katherine^Aff27; Vermeulen, Jessica^Aff28; Krevvata, Maria^Aff26; Lopez-Masi, Lorena^Aff27; Carey, Jodi^Aff26; Rowe, Melissa^Aff29; Carson, Robin^Aff26; Zweegman, Sonja^Aff30
Source:	Nature Medicine. 31(4):1366-1366
Database:	Springer Nature Journals